Schomäcker K, Scheidhauer K, Franke W G, Weiss S, Lindner L, Jantsch K, Shukla S K, Limouris G S
Klinik und Poliklinik für Nuklearmedizin, Universität zu Köln.
Nuklearmedizin. 1993 Apr;32(2):99-105.
169Yb complexes with known biokinetics in tumour-bearing mice up to 48 h p.i. were injected into healthy mice to study the radionuclide biodistribution in various organs and tissues for 672 h after injection, in order to obtain reliable biokinetic data in an animal model, not affected by tumour-growth, as a basis for the calculation of biological half-life and dose distribution. The results demonstrated the existence of at least two components with different biological half-lives in the organs and tissues investigated. The effective half-lives of these components decreased with increasing stability of the complexes administered. The effective half-life of the fast component was a few hours and that of the slow one between about 200 and 800 h.
将在接种肿瘤的小鼠中具有已知生物动力学(直至感染后48小时)的169Yb配合物注射到健康小鼠体内,以研究注射后672小时内各种器官和组织中的放射性核素生物分布,从而在不受肿瘤生长影响的动物模型中获得可靠的生物动力学数据,作为计算生物半衰期和剂量分布的基础。结果表明,在所研究的器官和组织中至少存在两种具有不同生物半衰期的成分。这些成分的有效半衰期随着所给药配合物稳定性的增加而降低。快速成分的有效半衰期为几小时,慢速成分的有效半衰期在约200至800小时之间。